Cargando…

Metabolic control of DNA methylation in naïve pluripotent cells

The naïve epiblast and embryonic stem cells (ESCs) give rise to all cells of the adult. Such developmental plasticity is associated with genome hypomethylation. Here we show that LIF/Stat3 signaling induces genomic hypomethylation via metabolic reconfiguration. Stat3-/- ESCs show decreased alpha-ket...

Descripción completa

Detalles Bibliográficos
Autores principales: Betto, Riccardo M, Diamante, Linda, Perrera, Valentina, Audano, Matteo, Rapelli, Stefania, Lauria, Andrea, Incarnato, Danny, Arboit, Mattia, Pedretti, Silvia, Rigoni, Giovanni, Guerineau, Vincent, Touboul, David, Stirparo, Giuliano Giuseppe, Lohoff, Tim, Boroviak, Thorsten, Grumati, Paolo, Soriano, Maria E, Nichols, Jennifer, Mitro, Nico, Oliviero, Salvatore, Martello, Graziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116828/
https://www.ncbi.nlm.nih.gov/pubmed/33526924
http://dx.doi.org/10.1038/s41588-020-00770-2
Descripción
Sumario:The naïve epiblast and embryonic stem cells (ESCs) give rise to all cells of the adult. Such developmental plasticity is associated with genome hypomethylation. Here we show that LIF/Stat3 signaling induces genomic hypomethylation via metabolic reconfiguration. Stat3-/- ESCs show decreased alpha-ketoglutarate production from glutamine, leading to increased Dnmt3a/b expression and DNA methylation. Notably, genome methylation is dynamically controlled by modulating alpha-ketoglutarate availability or Stat3 activation in mitochondria. Alpha-ketoglutarate links metabolism to the epigenome, by reducing the expression of Otx2 and its targets Dnmt3a/b. Genetic inactivation of Otx2 or Dnmt3a/b results in genomic hypomethylation even in the absence of active LIF/Stat3. Stat3-/- ESCs show increased methylation at Imprinting Control Regions and altered expression of cognate transcripts. Single-cell analysis of Stat3-/- embryos confirmed the dysregulated expression of Otx2, Dnmt3a/b and imprinted genes. Several cancers display Stat3-overactivation and abnormal DNA methylation, therefore the molecular module we described might be exploited under pathological conditions.